In this Monday, Nov. 23, 2015, photo, flags fly in front of Pfizer World Headquarters, in New York. Drugmaker Pfizer said that in November 2016 it will launch a less-expensive version of rival Johnson & Johnson’s blockbuster immune disorder drug, Remicade. Pfizer’s version, called Inflectra, will hit pharmacies in late November. It will be only the second so-called biosimilar drug available in the U.S. (AP Photo/Mark Lennihan)
Featured Photo Galleries
